Infections
|
July 3, 2025

Sepsis from Staphylococcus Infections

Medically Reviewed by
Updated On
July 9, 2025

Sepsis caused by Staphylococcus infections is a serious and potentially life-threatening complication that can arise from both community-acquired and healthcare-associated exposures. 

This article provides an overview of the clinical progression of Staphylococcus-related sepsis, including recognized risk factors, current treatment protocols, and preventive strategies aimed at reducing incidence and improving patient outcomes.

[signup]

Understanding Staphylococcus Infections

Staphylococcus, commonly called "staph," is a group of more than 30 bacteria. Almost all staph infections in humans are caused by the Staphylococcus aureus (Staph A) bacteria.

Staphylococcus aureus bacterial infection results in:

Staph A is a major cause of hospital-acquired infections of surgical wounds and infections associated with indwelling medical devices such as insulin pumps.

Staphylococci can be transmitted in several ways:

  • Human skin and mucous membranes are common habitats for staph bacteria, particularly in areas like the nose, mouth, armpits, and groin.
  • Healthcare settings, such as hospitals and nursing homes, pose a high risk due to vulnerable patients, frequent use of medical devices, and close human contact.
  • Contaminated surfaces and objects (like towels, bedding, doorknobs, and athletic equipment) can harbor staph and spread it through contact.
  • Improperly handled food can carry staph, especially if it hasn’t been adequately cleaned, processed, or stored.
  • Livestock may carry staph, and consuming contaminated meat or dairy products can lead to foodborne illness if not properly cooked or handled.
  • Surgical equipment that isn’t properly sterilized can serve as a direct transmission route, particularly in medical procedures.

A major concern in healthcare environments is Methicillin-Resistant Staphylococcus Aureus (MRSA). This strain is resistant to many antibiotics, making infections more challenging to treat and contributing to its status as a serious global health threat.

Symptoms and Diagnosis of Staphylococcal Sepsis

Staphylococcal sepsis is a life-threatening condition often triggered by Staphylococcus aureus, particularly the antibiotic-resistant strain MRSA.

According to the World Health Organization (WHO), sepsis is:

  • One of the most frequent causes of death worldwide
  • Responsible for 20% of all global deaths
  • Associated with 1.5% of all hospitalizations
  • Costly, with an average expense of $32,000 per infected patient annually

Early symptoms of staph-related sepsis may include:

  • Fever and chills
  • Rapid heart rate (over 100 beats per minute)
  • Accelerated breathing
  • Nausea or vomiting
  • Muscle pain and fatigue
  • Skin rash

If not treated promptly, these symptoms can progress to severe complications, such as:

  • Confusion or disorientation
  • Loss of consciousness
  • Intense pain
  • A rapid and dangerous drop in blood pressure

In some cases, less common or atypical symptoms may appear, including:

  • Low body temperature instead of a fever
  • Pale or mottled skin
  • Impaired kidney function
  • Panic attacks, nightmares, or hallucinations

Early recognition and treatment are critical to improving outcomes and reducing the risk of long-term complications or death.

Diagnostic Tools for Staph-Related Sepsis

When diagnosing staphylococcal sepsis, clinicians have several valuable tools at their disposal. These tests help confirm the diagnosis, identify the source of infection, and guide treatment decisions:

  • Serum lactate levels are an important early indicator, as elevated concentrations are linked to a higher risk of sepsis and worse outcomes. Initial lactate measurements also guide fluid resuscitation and treatment response.
  • Blood cultures, both aerobic and anaerobic, should be obtained from at least two separate sites to increase the chances of identifying the causative organism and ensuring appropriate antibiotic coverage.
  • Procalcitonin (PCT) is a helpful inflammatory biomarker for evaluating the severity of infection and can guide the duration of antibiotic therapy.
  • Standard laboratory tests such as a complete blood count (CBC), bilirubin, and creatinine levels provide insights into organ function and the systemic impact of the infection.
  • Chest X-rays can help confirm the presence of sepsis and may also reveal pulmonary sources of infection, such as pneumonia.
  • CT scans are beneficial when the source of infection is not immediately clear, as they can help identify deep-seated or complex infections and assess the extent of spread.
  • Ultrasound, especially point-of-care ultrasound (POCUS), is increasingly used in emergency settings to assess fluid status, guide resuscitation, and support rapid decision-making.

Together, these diagnostic tools play a critical role in the timely identification and management of sepsis, improving patient outcomes.

Causes and Risk Factors

Several underlying infections can lead to staphylococcal sepsis, particularly in high-risk settings or individuals. Common sources include:

  • Vascular catheters, especially when inserted in non-sterile conditions, can cause catheter-related bloodstream infections (CRBSIs), a leading trigger for sepsis.
  • Skin and soft tissue infections (SSTIs), including puncture wounds, cellulitis, burns, and surgical site infections, are common entry points for Staphylococcus aureus.
  • Osteoarticular infections, particularly those involving joint replacements, can serve as persistent reservoirs for bacteria.
  • Endocarditis, or infection of the heart valves, may progress to sepsis when bacteria spread through the bloodstream, leading to septic emboli or multi-organ damage.

Certain risk factors significantly increase the likelihood of developing sepsis:

  • A weakened immune system, such as in individuals with HIV, cancer, or those taking immunosuppressive medications following organ transplantation
  • Chronic illnesses, including diabetes, kidney failure, or chronic obstructive pulmonary disease (COPD)
  • Advanced age, which is associated with reduced immune function
  • Extended hospital stays, which increase exposure to invasive procedures and hospital-acquired infections, are a common source of sepsis

Recognizing these causes and risk factors is critical to early intervention and improving patient outcomes.

Treatment and Management

Treating sepsis involves immediate infection control and ongoing support for organ function.

Conventional medical management typically includes:

  • Broad-spectrum antibiotics to target the underlying infection as quickly as possible
  • Intravenous fluids to maintain blood pressure and prevent shock
  • Organ-specific therapies, such as oxygen for respiratory failure or dialysis in cases of kidney involvement

Supportive care is equally important and aims to stabilize the body and restore balance. This may involve:

  • Vasopressors like norepinephrine are used to raise dangerously low blood pressure
  • Insulin therapy to manage sepsis-related blood sugar spikes
  • Other targeted treatments based on the patient's clinical status

Some complementary strategies may be helpful to support recovery and long-term health. These may include:

  • Identifying and removing inflammatory triggers to reduce systemic stress
  • Nutritional support to enhance immune function and promote wound healing
  • Mental health interventions, such as mindfulness or counseling, are especially important in light of the increased risk for post-sepsis psychiatric disorders.

Prevention and Early Intervention

Preventing and detecting staphylococcus-related sepsis early when it occurs is critical to improving patient outcomes. Proactive strategies are essential because sepsis can progress rapidly once an infection takes hold.

Hygiene is one of the most effective and accessible tools for preventing infection, especially in healthcare environments such as hospitals and nursing homes. Both healthcare providers and patients should:

  • Follow strict handwashing and sanitizing protocols
  • Keep surgical sites, wounds, and incisions clean and properly covered
  • Avoid touching the face, particularly the eyes, nose, and mouth, to limit the spread of bacteria

Prophylactic strategies include:

  • Staying current on recommended vaccinations
  • Managing chronic conditions such as diabetes or kidney disease
  • Seeking prompt medical care at the first sign of infection
  • Implementing rigorous infection control practices, especially for high-risk individuals

If an infection occurs, early recognition and treatment are essential. Treatment should begin within the first hour of diagnosis to maximize the chances of survival and minimize complications. 

[signup]

Key Takeaways

  • Staph A is a major cause of sepsis
  • Early detection and treatment of infected regions is key to reducing the chance of an infection turning septic.
  • Healthcare teams should take extra precautions when dealing with patients at high risk for infections and sepsis and endeavor to teach those patients proper hygiene and wound care.
  • Treatment typically includes traditional care, such as broad-spectrum antibiotics, as well as integrative care, such as nutritional counseling and stress management.
  • Healthcare teams are encouraged to stay current on infectious prevention and care trends.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. ACEP. (n.d.). Point-of-care tools. ACEP. https://poctools.acep.org/POCTool/Sepsis(DART)/276ed0a9-f24d-45f1-8d0c-e908a2758e5a/
  2. Arefian H;Heublein S;Scherag A;Brunkhorst FM;Younis MZ;Moerer O;Fischer D;Hartmann M; (n.d.). Hospital-related cost of sepsis: A systematic review. The Journal of infection. https://pubmed.ncbi.nlm.nih.gov/27884733/
  3. Atkins, B. I., & Bowler, I. C. (n.d.). The diagnosis of large joint sepsis. The Journal of hospital infection. https://pubmed.ncbi.nlm.nih.gov/9868617/
  4. Brown, B. D., & Wood Watson, K. L. (2023, August 7). Cellulitis. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK549770/
  5. Burnham, J. P., & Kollef, M. H. (2018, April). Treatment of severe skin and soft tissue infections: A Review. Current opinion in infectious diseases. https://pmc.ncbi.nlm.nih.gov/articles/PMC6200137/
  6. Caraballo, C., & Jamies, F. (n.d.). Organ dysfunction in sepsis: An ominous trajectory from infection to death. The Yale journal of biology and medicine. https://pubmed.ncbi.nlm.nih.gov/31866778/
  7. Carrillo-Bayona, J. A., & Arias-Alvarez, L. (2017, August 2). Diagnostic Imaging in sepsis of Pulmonary Origin. Sepsis. https://pmc.ncbi.nlm.nih.gov/articles/PMC7120880/
  8. Centers for Disease Control and Prevention. (n.d.-a). Methicillin-resistant Staphylococcus aureus (MRSA) basics. Centers for Disease Control and Prevention. https://www.cdc.gov/mrsa/about/index.html
  9. Centers for Disease Control and Prevention. (n.d.-b). Preventing infections that can lead to sepsis. Centers for Disease Control and Prevention. https://www.cdc.gov/sepsis/prevention/index.html#:~:text=Prevention%20steps%20and%20strategies%20%0A%20%20,some%20infections%20that%20can%20lead%20to%20sepsis.
  10. Centers for Disease Control and Prevention. (n.d.-c). Staphylococcus aureus basics. Centers for Disease Control and Prevention. https://www.cdc.gov/staphylococcus-aureus/about/index.html
  11. Crapanzano, K. A., Hammarlund, R., Musso, M., Dlugolecki, L., Luce, L., Divers, R., Barnett, L., & D’Antonio, C. (2022). Impact of a mental health diagnosis on emergency department adherence to sepsis care guidelines. Ochsner journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC9196961/
  12. DeLeo, F. R., Malachowa, N., & Kobayashi, S. D. (n.d.). Pathogenesis of staphylococcus aureus abscesses - the American Journal of Pathology. Pathogenesis of Staphylococcus aureus Abscesses. https://ajp.amjpathol.org/article/S0002-9440(15)00070-X/fulltext
  13. Dellinger RP;Levy MM;Rhodes A;Annane D;Gerlach H;Opal SM;Sevransky JE;Sprung CL;Douglas IS;Jaeschke R;Osborn TM;Nunnally ME;Townsend SR;Reinhart K;Kleinpell RM;Angus DC;Deutschman CS;Machado FR;Rubenfeld GD;Webb SA;Beale RJ;Vincent JL;Moreno R; ; (n.d.). Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Critical care medicine. https://pubmed.ncbi.nlm.nih.gov/23353941/
  14. Di Serafino, M., Viscardi, D., Iacobellis, F., Giugliano, L., Barbuto, L., Oliva, G., Ronza, R., Borzelli, A., Raucci, A., Pezzullo, F., De Cristofaro, M. G., & Romano, L. (2021, June 5). Computed tomography imaging of septic shock. beyond the cause: The "CT hypoperfusion complex". A pictorial essay. Insights into imaging. https://pmc.ncbi.nlm.nih.gov/articles/PMC8178660/
  15. Elsaghir, H, & Khalili, Y. A. (n.d.). Septic Emboli. National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/31751017/
  16. Elsaghir, Hend, & Khalili, Y. A. (2023, June 26). Septic Emboli. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK549827/
  17. Evans L;Rhodes A;Alhazzani W;Antonelli M;Coopersmith CM;French C;Machado FR;Mcintyre L;Ostermann M;Prescott HC;Schorr C;Simpson S;Wiersinga WJ;Alshamsi F;Angus DC;Arabi Y;Azevedo L;Beale R;Beilman G;Belley-Cote E;Burry L;Cecconi M;Centofanti J;Coz Yataco . (n.d.). Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive care medicine. https://pubmed.ncbi.nlm.nih.gov/34599691/
  18. Foster, T. (1996, January 1). Staphylococcus. Medical Microbiology. 4th edition. https://www.ncbi.nlm.nih.gov/books/NBK8448/
  19. Francois B;Jeannet R;Daix T;Walton AH;Shotwell MS;Unsinger J;Monneret G;Rimmelé T;Blood T;Morre M;Gregoire A;Mayo GA;Blood J;Durum SK;Sherwood ER;Hotchkiss RS; (n.d.). Interleukin-7 restores lymphocytes in septic shock: The Iris-7 randomized clinical trial. JCI insight. https://pubmed.ncbi.nlm.nih.gov/29515037/
  20. Freeman, B. D., & Natanson, C. (n.d.). Anti-inflammatory therapies in sepsis and septic shock. Expert opinion on investigational drugs. https://pubmed.ncbi.nlm.nih.gov/11060768/
  21. Gahlot, R., Nigam, C., Kumar, V., Yadav, G., & Anupurba, S. (2014, April). Catheter-related bloodstream infections. International journal of critical illness and injury science. https://pmc.ncbi.nlm.nih.gov/articles/PMC4093967/
  22. Hansen, N. S., Nielsen, L. T., & Leh, S. (n.d.). Toxic Shock Syndrome. Ugeskrift for laeger. https://pubmed.ncbi.nlm.nih.gov/32400378/
  23. Hassoun, A., Friedman, B., & Linden, P. K. (n.d.). Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Critical care (London, England). https://pubmed.ncbi.nlm.nih.gov/28807042/
  24. Ibarz, M., Haas, L. E. M., Ceccato, A., & Artigas, A. (2024, January 10). The critically ill older patient with sepsis: A narrative review - annals of intensive care. SpringerOpen. https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-023-01233-7
  25. Institut Pasteur. (2024, September 3). Staphylococci. Institut Pasteur. https://www.pasteur.fr/en/medical-center/disease-sheets/staphylococci
  26. Johns Hopkins Medicine. (2024, April 29). Septicemia. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/septicemia
  27. Kamran, F., Tjandra, D., Heiler, A., & Virzi, J. (n.d.). Evaluation of sepsis prediction models before onset of treatment | NEJM AI. https://ai.nejm.org/doi/full/10.1056/AIoa2300032
  28. King, J., Heiler, A., England, P. C., & Chenoweth, C. E. (1970, January 1). Early recognition and initial management of sepsis in adult patients. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK598311/
  29. Li, D., Zhang, X., Lu, Y., Jing, L., Hu, H., Song, Y., Wu, S., & Zhu, W. (2024, July). Post-sepsis psychiatric disorder: Pathophysiology, prevention, and treatment. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. https://pmc.ncbi.nlm.nih.gov/articles/PMC11176234/
  30. Lowy, F. D. (1998, August 20). Staphylococcus aureus Infections. New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJM199808203390806?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
  31. Markwart, R., Saito, H., Harder, T., Tomczyk, S., Cassini, A., Fleischmann-Struzek, C., Reichert, F., Eckmanns, T., & Allegranzi, B. (2020, August). Epidemiology and burden of sepsis acquired in hospitals and Intensive Care Units: A systematic review and meta-analysis. Intensive care medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC7381455/
  32. Mer, M., Kwizera, A., Adhikari, N. K., & Schultz, M. J. (2019, February 9). Core elements of general supportive care for patients with sepsis and septic shock in resource-limited settings. Sepsis Management in Resource-limited Settings [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK553812/
  33. Momodu, I. I., & Savaliya, V. (2023, May 31). Osteomyelitis. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK532250/
  34. National Cancer Institute. (n.d.). NCI Dictionary of Cancer terms. Comprehensive Cancer Information - NCI. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cbc-with-differential#:~:text=Listen%20to%20pronunciation,%2C%20basophils%2C%20and%20eosinophils).
  35. National Collaborating Centre for Cancer (UK). (n.d.). Reducing the risk of septic complications of anticancer treatment. Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients. https://www.ncbi.nlm.nih.gov/books/NBK373666/
  36. NHS. (n.d.-a). Sepsis. NHS choices. https://www.nhs.uk/conditions/sepsis/
  37. NHS. (n.d.-b). Treatment and recovery - Sepsis . NHS choices. https://www.nhs.uk/conditions/sepsis/treatment-and-recovery/
  38. Pinchuk, I. V., Beswick, E. J., & Reyes, V. E. (2010, August). Staphylococcal enterotoxins. Toxins. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153290/
  39. Poulsen, K. B., Wachmann, C. H., & Jensen, A. G. (n.d.). Risk factors for hospital-acquired Staphylococcus aureus bacteremia | acid base, electrolytes, fluids | jama internal medicine | jama network. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/485076
  40. Rhee C;Chen T;Kadri SS;Lawandi A;Yek C;Walker M;Warner S;Fram D;Chen HC;Shappell CN;DelloStritto L;Klompas M; ; (n.d.). Trends in empiric broad-spectrum antibiotic use for suspected community-onset sepsis in US hospitals. JAMA network open. https://pubmed.ncbi.nlm.nih.gov/38935374/
  41. Ross, A., & Shoff, H. W. (2023, August 7). Toxic shock syndrome. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK459345/
  42. Rudd, K. E., Johnson, S. C., Ages, K. M., Shackelford, K. A., Tsoi, D., & Kievlan, D. R. (n.d.). Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Global, Regional, and National Sepsis Incidence and Mortality, 1990–2017: analysis for the Global Burden of Disease Study. https://www.thelancet.com/article/S0140-6736(19)32989-7/fulltext
  43. Schuetz P;Beishuizen A;Broyles M;Ferrer R;Gavazzi G;Gluck EH;González Del Castillo J;Jensen JU;Kanizsai PL;Kwa ALH;Krueger S;Luyt CE;Oppert M;Plebani M;Shlyapnikov SA;Toccafondi G;Townsend J;Welte T;Saeed K; (n.d.). Procalcitonin (pct)-guided antibiotic stewardship: An international experts consensus on optimized clinical use. Clinical chemistry and laboratory medicine. https://pubmed.ncbi.nlm.nih.gov/30721141/
  44. Shah, Y. R., Singh Dahiya, D., Chitagi, P., & Rabinowitz, L. G. (2023, June 10). Hyperbilirubinemia in a patient with sepsis: A diagnostic challenge. ACG case reports journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC10259638/
  45. Taylor, T. A., & Unakal, C. G. (2023, July 17). Staphylococcus aureus infection. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK441868/
  46. Tullo, G., Candelli, M., Gasparrini, I., Micci, S., & Franceschi, F. (2023, February 2). Ultrasound in sepsis and septic shock-from diagnosis to treatment. Journal of clinical medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC9918257/
  47. U.S. National Library of Medicine. (n.d.). Furunculosis (concept ID: C0016867) - MedGen - NCBI. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/medgen/42118
  48. Wang, K., Xie, S., Xiao, K., Yan, P., He, W., & Xie, L. (2018, April 24). Biomarkers of sepsis-induced acute kidney injury. BioMed research international. https://pmc.ncbi.nlm.nih.gov/articles/PMC5941779/
  49. Wischmeyer, P. E. (2018, January). Nutrition therapy in sepsis. Critical care clinics. https://pmc.ncbi.nlm.nih.gov/articles/PMC6447319/
  50. World Health Organization. (n.d.). Sepsis. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/sepsis#:~:text=The%20body%27s%20reaction%20causes%20damage,problems%20are%20at%20higher%20risk.
  51. Yallowitz, A. W., & Decker, L. C. (2023, April 24). Infectious endocarditis. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK557641/
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Infections
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Krista Anderson-Ross, ND for an insightful webinar, "Nutrient Depletion and Mental Wellness," on Wednesday, July 9 at 2:00 PM EST / 11:00 AM PT.

In this session, you'll gain insight into how nutrient patterns may influence cognitive and mitochondrial function, explore the role of nutrients like B vitamins, magnesium, zinc, and CoQ10, and learn how functional testing may help guide personalized nutrition strategies to support energy, mood, and overall mental resilience.

Register now to secure your spot.